Cardiovascular mortality in Russia and other countries

Slides:



Advertisements
Similar presentations
Russian Health profiles in Transition Eugene Shubnikov for FSU Internet Prevention Network.
Advertisements

Modelling the potential economic impact of investment in Public Health Professor Malcolm Whitfield Director of The Centre for Health & Social Care Research.
1 Excess Dietary Sodium: Impact on Hypertension and Health Outcomes Presenters name Institution Updated April 2011.
Epidemiology of Peripheral Vascular Disease Sohail Ahmed School of Population and Health Sciences.
The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) The LIPID Study Group N Engl J Med 1998;339:
Childe Hassam: “The South Ledges” Early 20 th Century American Impressionist: Note: light And color! (Very European…)
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Non-communicable diseases A global overview David Leon.
Body Weight and Mortality: New Population Based Evidences Body Weight and Mortality: New Population Based Evidences Dongfeng Gu, MD Dongfeng Gu, MD Fu.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Non-communicable diseases David Redfern
Global impact of ischemic heart disease World Heart Federation, 2011.
HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.
Heart diseases.
Do you know someone who has been a victim of a heart attack or stroke? VideoVideo - Watch your own heart attack.
Diabetes and the Heart Meet the experts August Responding to the challenge: determining health policy Introductory remarks Lars Rydén Department.
Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
HYPERTENSION BURDEN AND CVD RISK PREDICTION IN AFRICA.
Does Health Care Save Lives? The role of the health care system
Epidemiology of CV disease in Central and Eastern Europe Renata Cífková Center for CV Prevention, Charles University Medical School & Thomayer University.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
0CTOBER 2010 An Approach for Sub-Saharan Africa. Dr. Linda Hawker, MD, CCFP General Practice Kelowna BC Canada.
Modern Management of Cholesterol in the High-Risk Patient.
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
Alcohol and health of Russian men at working age Evidence from the Izhevsk studies ( ) David Leon London School of Hygiene & Tropical Medicine.
Studying mortality trends: The IMPACT CHD Policy Model
Physical Activity Trends ä Healthy People 2010 goal is to increase daily physical activity by 30% in adults. ä As of now 60% of the population is not active.
Cardiovascular diseases in Eastern Europe Martin Bobak University College London.
Innovations in Management of Cardiovascular Disease for Global Health
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
ASSOCIATION OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WITH INCIDENT CARDIOVASCULAR EVENTS IN WOMEN, BY LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN.
Cardiovascular Outcome Strategy Implications for Primary Care Westcliffe Medical Practice Shipley Westcliffe Cardiology Service Dr Matthew Fay Westcliffe.
Mobile Global Health Supercourse in the Former Soviet Union countries Eugene Shubnikov (Russia), Komil Daburov (Tajikistan), Andrey Troufanov (Russia)
Definition of the ‘health transition’ Trends of disease patterns in populations The 4 stages of the epidemiological transition The cardiovascular disease.
Pre-ALLHAT Drug Use IMS Health NDTI, Year % of Treated Patients on Medication CCBs Beta Blockers Diuretics ACE Inhibitors.
Can lifestyle moderate the burden of CVD? Evangelos Polychronopoulos, MD, MPH, PhD Asst Professor of Preventive Medicine Harokopio University.
An aortic aneurysm can rupture (dissecting aneurysm) and cause massive blood loss, circulatory shock and rapid death.
Health Statistics and Informatics Non-communicable diseases A global overview.
The Disease Control Priorities Project ( and Chronic Disease Presentation to the Hemispheric Meeting of the Social Protection.
Taking a life-course perspective – does previous drinking matter? Annie Britton Research Department of Epidemiology and Public Health University College.
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
Presentation Title R3 이지영 / 김 수 중교 수 님. Introduction Lowering LDL cholesterol levels with statins : Reduce the risk of cardiovascular disease Vascular.
The widespread decline in cardiovascular mortality : A poorly understood triumph David Leon London School of Hygiene & Tropical Medicine Arctic University.
Internal Medicine Workshop Series Laos September /October 2009.
Global health in the news h/study-shows-spread-of-cigarettes-in- china.html?ref=health&_r=0.
Alcohol-related mortality in European countries II Working Meeting on Adult Premature Mortality in European Union Warsaw, October 2006.
COUNTRY REPORT ON HEALTH STATUS LITHUANIA Jurate Klumbiene Institute for Biomedical Research Kaunas University of Medicine Meeting on adult premature mortality.
Cardiovascular Risk: A global perspective
1 Explanations of the East European Health Crises and Implications for Health and Social Policy.
Management of Hypertension according to JNC 7
International Project on Cardiovascular Disease in Russia
Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from the Irish Longitudinal Study on Ageing.
Preventing Cardiovascular Disease
A “Scottish effect” for health?
Cardiovascular risk factors: are they useful screening tests?
Recognizing Your Risk for Cardiovascular Disease
Cardiovascular Disease (CVD) in Texas
Stroke secondary prevention
Prevalence of statin and beta-blocker use by clinical presentation
Section I: RAS manipulation
The 50% Myth: Do we need new cardiovascular risk factors?
Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.
Heart Disease Dr Stasinos Theodorou
Characteristics of included studies
University College London
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Cardiovascular mortality in Russia and other countries David Leon (david.leon@lshtm.ac.uk) London School of Hygiene & Tropical Medicine, Arctic University of Norway, UiT Cardiovascular Epidemiology Course Kazan, April 2015

Global trends in life-expectancy at birth

Trends in life expectancy at birth by global region 1950-2010 World

Trends in life expectancy at birth by global region 1950-2010 N America Oceania Latin America Asia

Trends in life expectancy at birth by global region 1950-2010 Europe Africa

Recent European trends

Trends in European life expectancy 1970-2009 Source : Leon, IJE, 2011

Life expectancy at birth 1955 - 2010 EU members (pre-2005) Russia

Life expectancy at birth 1955 - 2010 Russia 64 (2011) UK 79 (2011) Russia 76 (2011) UK 83 (2011) Ru and Tatarstan from Evgueny Andreev. UK and Norway from GBD

Life expectancy at birth 1955 - 2010 EU members (pre-2005) Russia Gorbachev anti-alcohol campaign Gorbachev anti-alcohol campaign

Life expectancy at birth 1955 - 2010 EU members (pre-2005) Russia Collapse of Soviet Union Collapse of Soviet Union

Life expectancy at birth 1955 - 2010 EU members (pre-2005) Russia Chaos and economic liberalisation Chaos and economic liberalisation

Life expectancy at birth 1955 - 2010 EU members (pre-2005) Foreign currency crisis Russia Foreign currency crisis

Life expectancy at birth 1955 - 2010 EU members (pre-2005) Putin elected Russia Putin elected

Hazardous alcohol consumption strongly implicated in fluctuations

Strong evidence that alcohol drives fluctuations in male life expectancy in Russia 1965 -2008 Source : V. Shkolnikov and E. Andreev

Cardiovascular Disease

Two major classes of cardiovascular mortality Ischaemic Heart Disease (includes heart attack / myocardial infarction) Stroke (cerebrovascular event/accident)

Cardiovascular disease makes a major contribution to Russia’s low life expectancy Life expectancy at birth (years) in 2009 Men Women United Kingdom 78.1 82.3 Russian Federation 62.7 74.7 Difference (UK minus Russia) 15.4 7.6 Contribution of CVD to difference 7.5 6.3 Contribution of IHD to difference 4.0 3.2 Cardiovascular disease accounts for 49% of life expectancy difference between UK and Russia and 83% for women

International trends in cardiovascular mortality rates in adults from 1950 (30+ years) Source : M. Ezzati et al Nat.Rev.Cardiol. 2015 (In Press)

Men Women

Men Women

Russia and other former communist countries are different

Men Women

Explaining long term trends is difficult !

Classic Risk Factors for IHD Cholesterol (low-density lipoprotein) Smoking Obesity / Physical activity Blood pressure Diabetes

Revolution in treatment of cardiovascular disease Probably relatively little until the mid 1960s but then things gradually changed Hypertension Thiazide diuretics Beta blockers ACE inhibitors Lipids Statins Arrythmias Calcium channel blockers Pacemakers Catheter ablation Acute myocardial infarction Anti-arrhythmics Thrombolysis, now primary percutaneous coronary intervention Anti-platelet agents Secondary prevention with beta blockers, ACE inhibitors, anti-platelet agents, and statins

What explains the improvement in cardiovascular outcomes in western countries after 1980 ? Findings using the “IMPACT” model Note : This is a “model”

Explaining the fall in IHD deaths in the USA 1980-2000 NEJM 2007; 356: 2388. Risk Factors worse +17% Obesity (increase) +7% Diabetes (increase) +10% Risk Factors better -61% Population BP fall -20% Smoking -12% Cholesterol (diet) -24% Physical activity -5%  Treatments -47% AMI treatments -10% Secondary prevention -11% Heart failure -9% Angina:CABG & PTCA -5% Hypertension therapies -7% Statins (primary prevention) -5%   Unexplained -9% CHD deaths 341,745 fewer deaths in 2000  1980 2000

IHD mortality fall Poland 1991-2005 P. Bandoz et al BMJ 2012 Risk Factors worse +7% Obesity (increase) +4.5% Diabetes (increase) +2.5% Risk Factors better -66% Cholesterol (diet) -39% Smoking - 11% Physical activity -10% Population BP fall 0% (Men Women)  Treatments -38% AMI treatments -5 % Unstable angina -4% Secondary prevention -7% Heart failure -12% Angina: CABG surgery -2% Angina ASA - 1 % Hypertension therapies -2% Statins (Primary prevention) -3%   Unexplained -10% 26,200 fewer deaths in 2005  1991 2005 30

Understanding Ischaemic Heart Disease in Russia

Understanding Ischaemic Heart Disease in Russia ... Inadequate data ....

Smoking

Estimated contribution of smoking to circulatory disease mortality at ages 35-69 years 33% male deaths 3% female deaths [in 2010] The percentages were from report sent to DL on 14 May 2013 of updated analyses for 2010 Source : http://www.ctsu.ox.ac.uk/deathsfromsmoking/

But … smoking cannot explain massive fluctuations over time

Ischaemic heart disease mortality, in Russia, 1970 – 2010 (age <65 years) Men Age-standardised rate per 100,000 Russia UK Norway Source : WHO HFA database

Trends of adult smoking rates in Russia, 1992–2009 Source : Lunze K &Migliorini L. BMC Public Health 2013;13:64

Smoking cannot explain why Russian women have such high rates compared to other countries

Hypertension High rates in Russia compared to other European countries Poor rates of control Likely to be an important factor Note : no good national data available

Paradoxical lipid profile relative to other countries Prevalence of raised total cholesterol not high Levels of low density lipoprotein (LDL - bad cholesterol) tend to be average or below average Levels of high density lipoprotein (HDL - “good” cholesterol) above average Note : no good national data available

Lipid profiles in Russia, USA and Finland “Good” cholesterol marker “Bad” cholesterol marker Source : M. Averina et al Clin.Chem. 50 (2):346-354, 2004

Classic risk factors do not explain international differences 10-year Norwegian myocardial infarction risk score Men Women Arkhangelsk study (1999-2000) 33.8 3.9 Finnmark study (1987-88) 55.3 9.6 Tromsø study (1994-95) 45.9 9.8

Hazardous Drinking and CVD fluctuations

Source : Data provided by Evgueny Andreev

Heart disease (IHD) mortality in Russia is not typical Lipid profiles are not very pro-atherogenic relative to other countries although good data limited Very high excess burden cardiovasclar mortality at working ages relative to other countries Massive fluctuations in ischaemic heart disease mortality over time Hazardous alcohol drinking implicated (mechanism unclear) Many deaths attributed to “other ischaemic heart disease” [ICD10 I24]. Is there misclassification ?

Conclusion Reasons for Russia’s very high mortality from cardiovascular disease not fully understood Contribution of barriers to effective treatment unknown Alcohol effects are a challenge to the dominant view that it is cardioprotective

Спасибо Thank you